학술논문

Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Document Type
Article
Source
In: Biology of Blood and Marrow Transplantation. (Biology of Blood and Marrow Transplantation, September 2018, 24(9):1836-1840)
Subject
Language
English
ISSN
15236536
10838791